Thompson Davis & Co., Inc. Voyager Therapeutics, Inc. Transaction History

Thompson Davis & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.47 - $5.55 $28,283 - $63,553	-11,451 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $8,555 - $10,870	-500 Reduced 4.18%	11,451 $217,000
Q2 2018 Aug 03, 2018	BUY	$16.76 - $23.92 $130,728 - $186,576	7,800 Added 187.91%	11,951 $234,000
Q1 2018 May 02, 2018	SELL	$16.16 - $31.31 $53,877 - $104,387	-3,334 Reduced 44.54%	4,151 $78,000
Q4 2017 Feb 05, 2018	BUY	$12.26 - $25.88 $37,037 - $78,183	3,021 Added 67.67%	7,485 $124,000
Q3 2017 Oct 30, 2017	BUY	$8.37 - $20.59 $37,363 - $91,913	4,464	4,464 $92,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $206M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.